Giorgia Adamo

Dr. Giorgia Adamo

Institute for Biomedical Research and Innovation, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RMRamila Mammadova
Ramila Mammadova
SMSerena Maggio
Serena Maggio
IFImmacolata Fiume
Immacolata Fiume
RBRamesh Bokka
Ramesh Bokka
MMManeea Moubarak
Maneea Moubarak
Gabriella PocsfalviGabriella Pocsfalvi
Gabriella Pocsfalvi
Plant-derived nanovesicles (PDNVs) have become attractive alternatives to mammalian cell-derived extracellular vesicles (EVs) both as therapeutic approaches and drug-delivery vehicles. In this study, we isolated tomato fruit-derived NVs and separated them by the iodixanol density gradient ultracentrifugation (DGUC) into twelve fractions. Three visible bands were observed at densities 1.064 ± 0.007 g/mL, 1.103 ± 0.006 g/mL and 1.122 ± 0.012 g/mL. Crude tomato PDNVs and DGUC fractions were characterized by particle size-distribution, concentration, lipid and protein contents as well as protein composition using mass spectrometry-based proteomics. Cytotoxicity and anti-inflammatory activity of the DGUC fractions associated to these bands were assessed in the lipopolysaccharide (LPS)-stimulated human monocytic THP-1 cell culture. The middle and the low-density visible DGUC fractions of tomato PDNVs showed a significant reduction in LPS-induced inflammatory IL-1β cytokine mRNA production. Functional analysis of proteins identified in these fractions reveals the presence of 14-3-3 proteins, endoplasmic reticulum luminal binding proteins and GTP binding proteins associated to gene ontology (GO) term GO:0050794 and the regulation of several cellular processes including inflammation. The most abundant middle-density DGUC fraction was loaded with curcumin using direct loading, sonication and extrusion methods and anti-inflammatory activity was compared. The highest entrapment efficiency and drug loading capacity was obtained by direct loading. Curcumin loaded by sonication increased the basal anti-inflammatory activity of tomato PDNVs.

1 August 2017 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Giulia Di PrimaGiulia Di Prima
Giulia Di Prima
SSSilvia Saladino
Silvia Saladino
FBFlavia Bongiovì
Flavia Bongiovì
Giorgia AdamoGiorgia Adamo
Giorgia Adamo
GGGiulio Ghersi
Giulio Ghersi
Gaetano GiammonaGaetano Giammona
Gaetano Giammona

24 March 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
SPSabrina Picciotto
Sabrina Picciotto
PSPamela Santonicola
Pamela Santonicola
APAngela Paterna
Angela Paterna
EREstella Rao
Estella Rao
SRSamuele Raccosta
Samuele Raccosta
Giorgia AdamoGiorgia Adamo
Giorgia Adamo
Extracellular vesicles (EVs) are lipid membrane nano-sized vesicles secreted by various cell types for intercellular communication, found in all kingdoms of life. Nanoalgosomes are a subtype of EVs derived from microalgae with a sustainable biotechnological potential. To explore the uptake, distribution and persistence of nanoalgosomes in cells and living organisms, we separated them from a culture of the chlorophyte Tetraselmis chuii cells by tangential flow filtration (TFF), labelled them with different lipophilic dyes and characterized their biophysical attributes. Then we studied the cellular uptake of labelled nanoalgosomes in human cells and in C. elegans, demonstrating that they enter the cells through an energy dependent mechanism and are localized in the cytoplasm of specific cells, where they persist for days. Our data confirm that nanoalgosomes are actively uptaken in vitro by human cells and in vivo by C. elegans cells, supporting their exploitation as potential nanocarriers of bioactive compounds for theranostic applications.

23 November 2016 in Molecules
Verified
Journal Article
Open access
PDF file
Giorgia AdamoGiorgia Adamo
Giorgia Adamo
NGNatascia Grimaldi
Natascia Grimaldi
SCSimona Campora
Simona Campora
DBDonatella Bulone
Donatella Bulone
MBMaria Luisa Bondì
Maria Luisa Bondì
GGGiulio Ghersi
Giulio Ghersi
(1) Background: A new family of nanosystems able to discern between normal and tumor cells and to release a therapeutic agent in controlled way were synthetized by e-beam irradiation. This technique permits to obtain biocompatible, sterile, carboxyl-functionalized polyvinylpyrrolidone (PVP-co-acrylic acid) nanogels (NGs); (2) Methods: Here, we performed a targeting strategy based on the recognition of over-expressed proteins on tumor cells, like the folate receptor. The selective targeting was demonstrated by co-culture studies and flow cytometry analysis, using folate conjugated NGs. Moreover, nanoparticles were conjugated to a chemotherapeutic drug or to a pro-apoptotic siRNA through a glutathione sensitive spacer, in order to obtain a controlled release mechanism, specific for cancer cells. The drug efficiency was tested on tumor and healthy cells by flow cytometric analysis, confocal and epifluorescence microscopy and cytotoxicity assay; the siRNA effect was investigated by RNAi experiment; (3) Results: The data obtained showed that the use of NGs permits a faster cargo release in cancer cells, in response to high cytosolic glutathione level, also improving their efficacy; (4) Conclusion: The possibility of releasing biological molecules in a controlled way and to recognize a specific tumor target allows overcoming the typical limits of the classic cancer therapy.

18 May 2012 in Biomacromolecules
Verified
Journal Article
Closed access
CDClelia Dispenza
Clelia Dispenza
MSMaria Antonietta Sabatino
Maria Antonietta Sabatino
NGNatascia Grimaldi
Natascia Grimaldi
DBDonatella Bulone
Donatella Bulone
MBMaria Luisa Bondì
Maria Luisa Bondì
GGGiulio Ghersi
Giulio Ghersi

7 January 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Giorgia AdamoGiorgia Adamo
Giorgia Adamo
SPSabrina Picciotto
Sabrina Picciotto
PGPaola Gargano
Paola Gargano
APAngela Paterna
Angela Paterna
SRSamuele Raccosta
Samuele Raccosta
Antonella BongiovanniAntonella Bongiovanni
Antonella Bongiovanni
The application of extracellular vesicles (EVs) as therapeutics or nanocarriers in cell‐free therapies necessitates meticulous evaluations of different features, including their identity, bioactivity, batch‐to‐batch reproducibility, and stability. Given the inherent heterogeneity in EV preparations, this assessment demands sensitive functional assays to provide key quality control metrics, complementing established methods to ensure that EV preparations meet the required functionality and quality standards. Here, we introduce the detectEV assay, an enzymatic‐based approach for assessing EV luminal cargo bioactivity and membrane integrity. This method is fast, cost‐effective, and quantifiable through enzymatic units. Utilizing microalgae‐derived EVs, known as nanoalgosomes, as model systems, we optimised the assay parameters and validated its sensitivity and specificity in quantifying the enzymatic activity of esterases within the EV lumen while also evaluating EV membrane integrity. Compared to conventional methods that assess physicochemical features of EVs, our single‐step analysis efficiently detects batch‐to‐batch variations by evaluating changes in luminal cargo bioactivity and integrity across various EV samples, including differences under distinct storage conditions and following diverse isolation and exogenous loading methods, all using small sample sizes. The detectEV assay's application to various human‐derived EV types demonstrated its versatility and potential universality. Additionally, the assay effectively predicted EV functionality, such as the antioxidant activity of different nanoalgosome batches. Our findings underscore the detectEV assay's utility in comprehensive characterization of EV functionality and integrity, enhancing batch‐to‐batch reproducibility and facilitating their therapeutic applications.